Entrepreneurs

For Entrepreneurs

Looking for investors can be both exciting and nerve-wracking. We want to help make it as smooth as possible for you. Here’s what you need to know so you can be ready for a great Angel relationship with ATA.

2027 Ata Submission Deadlines to Be Considered for the Following Month:

Applications submitted by these dates will be considered for the Screening Meeting which takes place early the following month. There is no Screening Meeting in December.

Month Due Date
January 12/31/2026
February 1/31/2027
March 2/28/2027
April 3/29/2027
Month Due Date
May 4/30/2027
June 5/31/2027
July 6/28/2027
August 7/31/2027
Month Due Date
September 8/31/2027
October 9/30/2027
November 10/26/2027
January 2028

Atlanta Technology Angels Investment Criteria

​Types of Companies
We invest in technology-oriented businesses with the potential to scale rapidly and with capital efficiency.

​Geography
We work with companies based in the Southeast, especially in the greater Atlanta area.

Company Stage
ATA members invest primarily in startups that have moved beyond the concept and early prototype stages and are demonstrating customer validation.

Minimum: Working product with meaningful customer testing underway.
Preferred: Beta or commercially launched product with pilots, paid pilots, or early customers.
Ideal: Fully developed product with initial revenue and demonstrated customer demand.
Exception: For companies developing products that require FDA approval, ATA members will consider companies at an earlier stage when funding will support required clinical testing, regulatory approval, and commercialization.

Featured-Image-Right

​Management Team
We’re looking for talented management teams that demonstrate vision, focus, and the ability to execute. Prior CEO and domain experience are big pluses.

​Fundraising Round
We do 6-8 deals per year. We invest between $100k-$300k in deals. This means:

  • We lead rounds of $300k – $750k. Typically a convertible note with 6% interest, 20% discount, and a valuation cap between $2M – $12M.
  • We participate in a variety of “angel deals” if you already have a lead investor and defined terms.
  • We can also fill out priced rounds of various sizes and security types if you have a lead investor and 75% of the target round committed.

​Industries
We’re interested in companies that leverage technology to create disruption. For medical device and biotech companies, we prefer products and services with a clear regulatory path. We generally do not invest in pharmaceuticals.

For Entrepreneurs

Looking for investors can be both exciting and nerve-wracking. We want to help make it as smooth as possible for you. Here’s what you need to know so you can be ready for a great Angel relationship with ATA.

2027 Ata Submission Deadlines to Be Considered for the Following Month.

Applications submitted by these dates will be considered for the Screening Meeting which takes place early the following month. There is no Screening Meeting in December.

Month Due Date
January 12/31/2026
February 1/31/2027
March 2/28/2027
April 3/29/2027
May 4/30/2027
June 5/31/2027
July 6/28/2027
August 7/31/2027
September 8/31/2027
October 9/30/2027
November 10/26/2027
January 2028
Featured-Image-Right

Atlanta Technology Angels Investment Criteria

​Types of Companies
We invest in technology-oriented businesses with the potential to scale rapidly and with capital efficiency.

​Geography
We work with companies based in the Southeast, especially in the greater Atlanta area.

Company Stage
ATA members invest primarily in startups that have moved beyond the concept and early prototype stages and are demonstrating customer validation.

Minimum: Working product with meaningful customer testing underway
Preferred: Beta or commercially launched product with pilots, paid pilots, or early customers.
Ideal: Fully developed product with initial revenue and demonstrated customer demand.
Exception: For companies developing products that require FDA approval, ATA members will consider companies at an earlier stage when funding will support required clinical testing, regulatory approval, and commercialization.

​Management Team
We’re looking for talented management teams that demonstrate vision, focus, and the ability to execute. Prior CEO and domain experience are big pluses.

​Fundraising Round
We do 6-8 deals per year. We invest between $100k-$300k in deals. This means:

  • We lead rounds of $300k – $750k. Typically a convertible note with 6% interest, 20% discount, and a valuation cap between $2M – $12M.
  • We participate in a variety of “angel deals” if you already have a lead investor and defined terms.
  • We can also fill out priced rounds of various sizes and security types if you have a lead investor and 75% of the target round committed.

​Industries
We’re interested in companies that leverage technology to create disruption. For medical device and biotech companies, we prefer products and services with a clear regulatory path. We generally do not invest in pharmaceuticals.

Submission & Application Screening Process

Our application process is designed to simplify company and deal evaluations. Please submit a confidential pre-screening application below!

  • All companies are pre-screened before they are selected to present to a screening committee.
  • Companies that are selected (considered to be “due diligence ready”), will be scheduled to present at a monthly member meeting.
  • If there is interest in pursuing your opportunity, you will be assigned a “deal lead” who will shepherd you through due diligence and investment process.
  • Neither Atlanta Technology Angels nor its members pay finders fees or any similar fees to any person or entity in any way connected with investments made by its members; only members may process investment opportunities.
  • We do not charge companies for making presentations to members of the group.

From Entrepreneurs

When Mowgli was raising it’s seed round, the ATA came in swiftly to fill it out and then some. A few of the ATA members have been some of our most active and supportive investors. We’ve since taken on Series A funding from a strategic partner, but based on our experience we continue to recommend the ATA to entrepreneurs looking for angel funding.

Marshall Seese , Founder & CEO, Mowgli Games

Working with ATA was a pleasure. They are a very welcoming and professional group. Members were highly engaged, and their questions revealed potential opportunities for the growth of mPATH. I appreciated the clear communication with frequent updates throughout the diligence process.

Dave Miller , Founder & CEO, mPATH

Halo-logo-2

Atlanta Technology Angels Pre-Screening Applications

All ATA Pre-Screening Applications MUST be submitted to us via this link.
​NOTE: Do not include confidential information. Neither ATA nor its members sign Non-Disclosure Agreements for initial proposals. If there is sufficient interest, an NDA may be negotiated with individual members at a later time